ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOHSIN HISAMUDDIN M.D.

Internal Medicine

3,173

$156K

169
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

RICHARD WRIGHT MD

Internal Medicine

15,600

$762K

609
422 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

OLUGBENGA AWE MD

Internal Medicine

7,057

$360K

289
183 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

ASHOK KANCHARLA M.D.

Internal Medicine

45,670

$2.09M

943
603 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

43%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

GEORGE PURSLEY MD

Internal Medicine

46,881

$2.55M

1386
1046 are 65+

25%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

WENDY GOZA M.D.

Internal Medicine

6,409

$280K

188
166 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

HAMILTON EMOKPAE M.D.

Internal Medicine

9,827

$610K

277
150 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $56

GUY EASTERLING DO

Internal Medicine

15,082

$881K

498
372 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

BERNARD OREWA MD

Internal Medicine

8,557

$465K

292
178 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

RAGHU LOLABHATTU MD

Internal Medicine

23,873

$1.11M

435
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

EMORY SMITH MD

Internal Medicine

7,321

$435K

240
200 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $56

M. POWELL MD

Internal Medicine

20,542

$980K

645
542 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

PAUL HARVEY MD

Internal Medicine

18,352

$952K

678
470 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

SANJAY NARIANI M.D.

Internal Medicine

8,894

$512K

285
242 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

JOSEPH HERREN MD

Internal Medicine

28,835

$1.96M

837
727 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $56

MCKINLEY BAIN

Internal Medicine

20,866

$1.07M

582
433 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

LUTHER THOMAS M.D.

Internal Medicine

16,284

$879K

479
393 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

TUAN NGUYEN M.D.

Internal Medicine

8,459

$455K

228
204 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

OLADAYO OSINUGA MD

Internal Medicine

8,406

$465K

347
207 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

CHELUKALA REDDY M.D.

Internal Medicine

30,125

$1.14M

645
373 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

53%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

MAGED ABDELMALIK M.D.

Internal Medicine

24,652

$1.34M

546
412 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

GUIDO RING MD

Internal Medicine

40,028

$2.09M

841
610 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

CHIRAG PATEL M.D.

Internal Medicine

10,277

$415K

376
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

WENTZELLE KITCHENS M.D.

Internal Medicine

23,125

$1.06M

707
583 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

RAVINDER KURL MD

Internal Medicine

9,468

$421K

304
205 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank